Product Name

  • Name

    Deferoxamine mesylate

  • EINECS 205-314-3
  • CAS No. 138-14-7
  • Article Data1
  • CAS DataBase
  • Density
  • Solubility
  • Melting Point 148-149°
  • Formula C25H48N6O8.CH4O3S
  • Boiling Point 966.9 °C at 760 mmHg
  • Molecular Weight 656.798
  • Flash Point 538.5 °C
  • Transport Information
  • Appearance white to off-white powder
  • Safety 22-24/25
  • Risk Codes
  • Molecular Structure Molecular Structure of 138-14-7 (Deferoxamine mesylate)
  • Hazard Symbols
  • Synonyms Deferoxamine mesilate (JP14);Desferal;Prestwick_988;Deferoxamine mesylate (USP);Butanediamide,N'-[5-[[4-[[5-(acetylhydroxyamino) pentyl]amino]-1,4-dioxobutyl]hydroxyamino] pentyl]-N-(5-aminopentyl)-Nhydroxy-,monomethanesulfonate (salt);Desferal (TN);
  • PSA 268.59000
  • LogP 2.98900

Synthetic route

deferoxamine mesylate
138-14-7

deferoxamine mesylate

89Zr(Ox)2

89Zr(Ox)2

C25H45N6O8(89)Zr

C25H45N6O8(89)Zr

Conditions
ConditionsYield
With sodium carbonate In water at 24℃; for 0.25h; pH=7 - 7.5;100%
succinic acid anhydride
108-30-5

succinic acid anhydride

deferoxamine mesylate
138-14-7

deferoxamine mesylate

N-Succinyl-desferri-ferrioxyamin B
84211-47-2

N-Succinyl-desferri-ferrioxyamin B

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 42h; Inert atmosphere;97%
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 50℃; Solvent; Temperature; Inert atmosphere;
With pyridine at 20℃; Inert atmosphere;0.232 g
2-benzyloxybenzoyl chloride
4349-62-6

2-benzyloxybenzoyl chloride

deferoxamine mesylate
138-14-7

deferoxamine mesylate

N,O',O'',O'''-Tetra(2-benzyloxy-benzoyl)desferri-ferrioxamin B
101536-58-7

N,O',O'',O'''-Tetra(2-benzyloxy-benzoyl)desferri-ferrioxamin B

Conditions
ConditionsYield
With sodium hydrogencarbonate In diethyl ether; water for 1h;93%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

biotin N-Hydroxysuccinimide ester
35013-72-0

biotin N-Hydroxysuccinimide ester

DFOB-AdA
1150314-06-9

DFOB-AdA

Conditions
ConditionsYield
With sodium hydroxide In methanol at 40℃; for 4h; Product distribution / selectivity;92%
1-(N-succinimidyloxycarbonyl)adamantane
28320-76-5

1-(N-succinimidyloxycarbonyl)adamantane

deferoxamine mesylate
138-14-7

deferoxamine mesylate

DFOB-AdA
1150314-06-9

DFOB-AdA

Conditions
ConditionsYield
Stage #1: deferoxamine mesylate With sodium hydroxide In methanol
Stage #2: 1-(N-succinimidyloxycarbonyl)adamantane In methanol at 55℃; for 4h; Product distribution / selectivity;		92%
1 ,4-phenylenediisothiocyanate
4044-65-9

1 ,4-phenylenediisothiocyanate

deferoxamine mesylate
138-14-7

deferoxamine mesylate

N-[5-({3-[5-(acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-hydroxy-N'-{5-[3-(4-isothiocyanato-phenyl)-thioureido]-pentyl}-succinamide
1222468-90-7

N-[5-({3-[5-(acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-hydroxy-N'-{5-[3-(4-isothiocyanato-phenyl)-thioureido]-pentyl}-succinamide

Conditions
ConditionsYield
With triethylamine In chloroform; water; isopropyl alcohol85%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

deferoxamine mesylate
138-14-7

deferoxamine mesylate

1-(tert-Butoxycarbonyl)-7,18,29-trihydroxy-8,11,19,22,30-pentaoxo-1,7,12,18,23,29-hexaazahentriacontane
106339-54-2

1-(tert-Butoxycarbonyl)-7,18,29-trihydroxy-8,11,19,22,30-pentaoxo-1,7,12,18,23,29-hexaazahentriacontane

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water at 40℃; for 16h;83%
With sodium carbonate In 1,4-dioxane; water
deferoxamine mesylate
138-14-7

deferoxamine mesylate

3,4-diethoxy-3-cyclobuten-1,2-dione
5231-87-8

3,4-diethoxy-3-cyclobuten-1,2-dione

C31H52N6O11

C31H52N6O11

Conditions
ConditionsYield
Stage #1: deferoxamine mesylate With N-ethyl-N,N-diisopropylamine In ethanol at 50℃; for 1h;
Stage #2: 3,4-diethoxy-3-cyclobuten-1,2-dione In ethanol at 50℃; for 0.5h;		83%
Stage #1: deferoxamine mesylate With N-ethyl-N,N-diisopropylamine In ethanol at 50℃; for 1h;
Stage #2: 3,4-diethoxy-3-cyclobuten-1,2-dione In ethanol at 50℃; for 0.5h;		83%
C19H22N2O9

C19H22N2O9

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C41H67N7O14

C41H67N7O14

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide for 4h;82%
3,5-dimethyl-1-adamantanecarboxylic acid
14670-94-1

3,5-dimethyl-1-adamantanecarboxylic acid

deferoxamine mesylate
138-14-7

deferoxamine mesylate

DFOB-AdAdMe
1149568-52-4

DFOB-AdAdMe

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;80%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

(adamant-1-yl)-acetic acid
4942-47-6

(adamant-1-yl)-acetic acid

DFOB-AdAc
1149568-54-6

DFOB-AdAc

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;80%
aluminum(III) nitrate nonahydrate

aluminum(III) nitrate nonahydrate

deferoxamine mesylate
138-14-7

deferoxamine mesylate

(Al(III)desferrioxamin B complex)CH3SO3

(Al(III)desferrioxamin B complex)CH3SO3

Conditions
ConditionsYield
With potassium hydroxide In water addn. of desferal to fresh prepared Al(OH)3 gel in water (by hydrolysis of Al(NO3)3 with a pH 10 NH4+/NH3 buffer soln. or 0.5 m KOH soln.), stirring overnight; filtn. and solvent removal under vac., elem. anal., mixt. of 2 isomers;78%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

2-tert-butoxycarbonylamino-3-(tritylsulfanyl)propionic acid 2,5-dioxopyrrolidin-1-yl ester
87242-61-3, 75179-29-2

2-tert-butoxycarbonylamino-3-(tritylsulfanyl)propionic acid 2,5-dioxopyrrolidin-1-yl ester

tert-butyl (12,23,34-trihydroxy-5,13,16,24,27,35-hexaoxo-1,1,1-triphenyl-2-thia-6,12,17,23,28,34-hexaazahexatriacontan-4-yl)carbamate

tert-butyl (12,23,34-trihydroxy-5,13,16,24,27,35-hexaoxo-1,1,1-triphenyl-2-thia-6,12,17,23,28,34-hexaazahexatriacontan-4-yl)carbamate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 18h;77%
C15H18ClNO5

C15H18ClNO5

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C40H65N7O13

C40H65N7O13

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 0 - 20℃;74%
2-(4-methylphenoxy)acetic acid
940-64-7

2-(4-methylphenoxy)acetic acid

deferoxamine mesylate
138-14-7

deferoxamine mesylate

DFOB-MPOAc
1149568-53-5

DFOB-MPOAc

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;73%
2-(1-imidazolyl)acetic acid hydrochloride

2-(1-imidazolyl)acetic acid hydrochloride

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C30H52N8O9

C30H52N8O9

Conditions
ConditionsYield
Stage #1: 2-(1-imidazolyl)acetic acid hydrochloride; deferoxamine mesylate With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 45℃; for 1h; Inert atmosphere;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 8h;		72%
1-octyl-3-(carboxymethyl)-imidazolium bromide
1309877-54-0

1-octyl-3-(carboxymethyl)-imidazolium bromide

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C38H69N8O9(1+)*CH3O3S(1-)

C38H69N8O9(1+)*CH3O3S(1-)

Conditions
ConditionsYield
Stage #1: 1-octyl-3-(carboxymethyl)-imidazolium bromide; deferoxamine mesylate With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 50℃; for 1h; Inert atmosphere;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;		71%
hydrated ferric ammonium sulfate

hydrated ferric ammonium sulfate

deferoxamine mesylate
138-14-7

deferoxamine mesylate

ferrioxamine B perchlorate pentahydrate
82265-74-5

ferrioxamine B perchlorate pentahydrate

Conditions
ConditionsYield
With perchloric acid; sodium hydrogencarbonate In water ligand was dissolved in H2O, Fe-salt was added with stirring for 30 min, solid NaHCO3 was added, stirred for 1 h, filtered, passed through anion-exchange column (HClO4), washed, solvent was removed under reduced pressure, dissolved in MeOH, filtered; poured with excess of EtOAc with stirring, collected by centrifugation,redissolved in MeOH, filtered, EtOAc was added, collected, supernatant was decanted, solvent was slowly removed under midl vac. in vac. desiccator at 90°C for 2 d; elem. anal;70%
1-Adamantanecarboxylic acid
828-51-3

1-Adamantanecarboxylic acid

deferoxamine mesylate
138-14-7

deferoxamine mesylate

DFOB-AdA
1150314-06-9

DFOB-AdA

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;70%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

1-carboxymethyl-3-hydroxy-2-methylpyridin-4-one
60603-99-8

1-carboxymethyl-3-hydroxy-2-methylpyridin-4-one

DFOB-L1D
1149568-64-8

DFOB-L1D

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;70%
6-dibenzocyclooctynamidehexanoic acid

6-dibenzocyclooctynamidehexanoic acid

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C46H65N7O10

C46H65N7O10

Conditions
ConditionsYield
Stage #1: 6-dibenzocyclooctynamidehexanoic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: deferoxamine mesylate With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;		69%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

trolox
56305-04-5, 53188-07-1

trolox

N1-hydroxy-N-(5-(4-(hydroxy(1-(6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxamido)-1λ5,5λ3-pentyl)amino)-4-oxobutanamido)pentyl)-N4-(5-(N-hydroxyacetamido)pentyl)succinamide

N1-hydroxy-N-(5-(4-(hydroxy(1-(6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxamido)-1λ5,5λ3-pentyl)amino)-4-oxobutanamido)pentyl)-N4-(5-(N-hydroxyacetamido)pentyl)succinamide

Conditions
ConditionsYield
Stage #1: trolox With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 1h; Inert atmosphere;
Stage #2: deferoxamine mesylate In N,N-dimethyl-formamide for 16h; Inert atmosphere;		68.8%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

biotin N-Hydroxysuccinimide ester
35013-72-0

biotin N-Hydroxysuccinimide ester

biotin-DFOB
148942-68-1

biotin-DFOB

Conditions
ConditionsYield
Stage #1: deferoxamine mesylate With sodium hydroxide In methanol
Stage #2: biotin N-Hydroxysuccinimide ester In methanol at 55℃; for 4h;		68%
With sodium hydroxide In methanol at 60℃; Inert atmosphere;55%
1-carboxymethyl-3-methyl-3H-imidazolium bromide
671793-14-9

1-carboxymethyl-3-methyl-3H-imidazolium bromide

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C31H55N8O9(1+)*CH3O3S(1-)

C31H55N8O9(1+)*CH3O3S(1-)

Conditions
ConditionsYield
Stage #1: 1-carboxymethyl-3-methyl-3H-imidazolium bromide; deferoxamine mesylate With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 50℃; for 1h; Inert atmosphere;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;		68%
C29H45N3O13

C29H45N3O13

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C54H91N9O20

C54H91N9O20

Conditions
ConditionsYield
Stage #1: C29H45N3O13 With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide for 0.166667h;
Stage #2: deferoxamine mesylate In dimethyl sulfoxide for 3h;		68%
1-butyl-3-(carboxymethyl)-imidazolium bromide
1309877-52-8

1-butyl-3-(carboxymethyl)-imidazolium bromide

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C34H61N8O9(1+)*CH3O3S(1-)

C34H61N8O9(1+)*CH3O3S(1-)

Conditions
ConditionsYield
Stage #1: 1-butyl-3-(carboxymethyl)-imidazolium bromide; deferoxamine mesylate With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 50℃; for 1h; Inert atmosphere;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;		66%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

deferasirox
201530-41-8

deferasirox

DFOB-LDX
1149568-62-6

DFOB-LDX

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;65%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

C25H46N8O8

C25H46N8O8

Conditions
ConditionsYield
Stage #1: deferoxamine mesylate With potassium carbonate In methanol at 20℃; for 0.5h;
Stage #2: With copper(ll) sulfate pentahydrate; 3-azidosulfonyl-3H-imidazole-1-ium hydrogen sulfate In methanol; water at 20℃; for 4.5h;		65%
2-[({[(1S,2E,6S)-6-{[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}-6-methylcyclooct-2-en-1-yl]oxy}carbonyl)(methyl)amino]acetic acid

2-[({[(1S,2E,6S)-6-{[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}-6-methylcyclooct-2-en-1-yl]oxy}carbonyl)(methyl)amino]acetic acid

deferoxamine mesylate
138-14-7

deferoxamine mesylate

C43H70N8O15

C43H70N8O15

Conditions
ConditionsYield
Stage #1: 2-[({[(1S,2E,6S)-6-{[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}-6-methylcyclooct-2-en-1-yl]oxy}carbonyl)(methyl)amino]acetic acid With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide for 0.166667h;
Stage #2: deferoxamine mesylate In dimethyl sulfoxide for 3h;		64%
deferoxamine mesylate
138-14-7

deferoxamine mesylate

(R)-trolox
53101-49-8

(R)-trolox

(R)-N1-hydroxy-N1-(5-(4-(hydroxy(1-(6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxamido)-1λ5,5λ3-pentyl)amino)-4-oxobutanamido)pentyl)-N-(5-(N-hydroxyacetamido)pentyl)succinamide

(R)-N1-hydroxy-N1-(5-(4-(hydroxy(1-(6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxamido)-1λ5,5λ3-pentyl)amino)-4-oxobutanamido)pentyl)-N-(5-(N-hydroxyacetamido)pentyl)succinamide

Conditions
ConditionsYield
Stage #1: (R)-trolox With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 1h; Inert atmosphere;
Stage #2: deferoxamine mesylate In N,N-dimethyl-formamide for 16h; Inert atmosphere;		62%

Deferoxamine mesylate Chemical Properties

Molecular Structure of Deferoxamine mesylate (CAS NO.138-14-7):

IUPAC Name: N-[5-[[4-[5-[Acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide ; Methanesulfonic acid
Molecular Weight: 656.78968 [g/mol]
Molecular Formula: C26H52N6O11S
H-Bond Donor: 7
H-Bond Acceptor: 12 
EINECS: 205-314-3 
Storage temp.: −20 °C
Solubility: H2O: 50 mg/mL
Appearance: white to off-white  powder
Flash Point: 538.5 °C
Enthalpy of Vaporization: 152.67 kJ/mol
Boiling Point: 966.9 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25 °C
Classification Code: Antidote [to iron poisoning]; Chelating agent; Drug / Therapeutic Agent; Human Data

Deferoxamine mesylate Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo parenteral 16gm/kg/34W-I (16000mg/kg) CARDIAC: PERICARDITIS

GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE

BLOOD: OTHER CHANGES		 American Journal of Kidney Diseases. Vol. 10, Pg. 71, 1987.
man TDLo subcutaneous 143mg/kg/4D-I (143mg/kg) SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

GASTROINTESTINAL: NAUSEA OR VOMITING		 British Medical Journal. Vol. 291, Pg. 448, 1985.
mouse LD50 intraperitoneal 1240mg/kg (1240mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 1181, 1973.
mouse LD50 intravenous 273mg/kg (273mg/kg)   Drugs in Japan Vol. 6, Pg. 496, 1982.
mouse LD50 oral 15200mg/kg (15200mg/kg)   Drugs in Japan Vol. 6, Pg. 496, 1982.
mouse LD50 subcutaneous 1280mg/kg (1280mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 1181, 1973.
rat LD50 intravenous 330mg/kg (330mg/kg)   Drugs in Japan Vol. 6, Pg. 496, 1982.
rat LD50 oral 17300mg/kg (17300mg/kg)   Drugs in Japan Vol. 6, Pg. 496, 1982.
rat LD50 subcutaneous 5500mg/kg (5500mg/kg)   Drugs in Japan Vol. 6, Pg. 496, 1982.
women TDLo subcutaneous 150mg/kg/4D-I (150mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

GASTROINTESTINAL: NAUSEA OR VOMITING		 British Medical Journal. Vol. 291, Pg. 448, 1985.
women TDLo unreported 900mg/kg/30W- (900mg/kg) BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES

CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA		 American Journal of Medicine. Vol. 87, Pg. 468, 1989.

Deferoxamine mesylate Safety Profile

Safety Information of Deferoxamine mesylate (CAS NO.138-14-7):
Safety Statements: 22-24/25
 S22:Do not breathe dust. 
S24/25:Avoid contact with skin and eyes.
WGK Germany: 2
RTECS: UG5310000
Poison by intravenous route. Moderately toxic by subcutaneous and intraperitoneal routes. Mildly toxic by ingestion. Human systemic effects: acute pulmonary edema, blood changes, cardiomyopathy, degenerative brain changes, diarrhea, hypermotility, nausea or vomiting, pericarditis, ulceration or bleeding from small intestine, visual field changes. When heated to decomposition it emits toxic fumes of NOx and SOx.

Deferoxamine mesylate Specification

 Deferoxamine mesylate (CAS NO.138-14-7), its Synonyms are Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate ; Desferal methanesulfonate ; Desferrioxamine B mesylate ; Desferrioxamine B methanesulfonate ; Desferrioxamine mesylate ; Desferrioxamine methanesulfonate ; N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt) .

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View